The European Diabetes Study Center has gathered a team of renowned scientific and medical experts, pioneers in their field of expertise, to fund a biotech company, ILONOV, focused on developing a novel class of therapeutics using the therapeutic potential of our muscle-derived biologic. We aim at satisfying unmet medical needs in Type 1 Diabetes therapy by bringing to the market a first-in-class treatment for curing and preventing T1D and using our discovery to open up a new field of therapeutics.
| Employees | 7 (4 on RocketReach) |
| Founded | 2020 |
| Address | Boulevard René Leriche, Strasbourg, Grand Est 67200, FR |
| Industry | Biotechnology Research |
Looking for a particular ILONOV employee's phone or email?
Anastasia Grabarz is the CEO of ILONOV.
4 people are employed at ILONOV.
ILONOV is based in Strasbourg, Grand Est.